Pharmaceutical Research and Manufacturers of America
1 Leadership 2 Programs 3 See also 4 References 5 External links
George A. Scangos, CEO of Biogen, is chairman of the PhRMA board.
Joaquin Duato, chairman of Johnson & Johnson's pharmaceutical
division, is chairman-elect and Joseph Jimenez, CEO of Novartis, is
Previous leadership includes: John J. Castellani, formerly head of the
Business Roundtable, a U.S. advocacy and lobbying group and Billy
Tauzin, a former Republican congressman from Louisiana.
The company has notably opposed market pricing strategies of Valeant
Pharmaceuticals, deriding the firm as having a strategy "reflective of
a hedge fund".
SMARxT Disposal is a joint program run by the U.S. Fish and Wildlife
Service, the American Pharmacists Association, and PhRMA to encourage
consumers to properly dispose of unused medicines to avoid harm to the
The Partnership for Prescription Assistance is a program by PhRMA and
its member companies that connects patients in-need with information
on low-cost and free prescription medication. PhRMA has in 2017
raised concerns over price increases for generic drugs out of patent
by the company
Association of the British Pharmaceutical Industry Ethics in pharmaceutical sales European Federation of Pharmaceutical Industries and Associations (EFPIA) Generic Pharmaceutical Association International Federation of Pharmaceutical Manufacturers Associations (IFPMA) International Intellectual Property Alliance (IIPA) Japan Pharmaceutical Manufacturers Association Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme Pharmaceutical marketing SAFE-BioPharma Association (SAFE)
^ a b "Pharmaceutical Research and Manufacturers of America". National
Health Council. 2014-11-04. Retrieved 2017-12-11.
^ The Editorial Board (November 27, 2015). "Turn the Volume Down on
Drug Ads". New York Times. Retrieved November 27, 2015.
^ Stephen J. Ubl to Lead PhRMA as Next President and CEO. PhRMA
website. September 25, 2015